---
figid: PMC8569340__ajcr0011-5155-f1
figtitle: 'Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current
  chemotherapy'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8569340
filename: ajcr0011-5155-f1.jpg
figlink: /pmc/articles/PMC8569340/figure/fig01/
number: F1
caption: Akt as the master regulator of chemoresistance in breast cancer cells. Akt
  and its metabolic roles in breast cancer. PI3K activates Akt through Akt recruitment
  at the plasma membrane. In the case of RAS overactivation, KRAS alternatively activates
  Akt signalling in an RTK-independent manner. KRAS-dependent activation of Akt upregulates
  HIF-1α and Nrf2 transcription factors by which numerous genes related to glucose
  metabolism (e.g., glucose transporter 1), MDRs (e.g., BCRP, MDR1, and P-gp), antioxidants
  (e.g., HO-1 and NAD(P)H dehydrogenase 1/2), cancer stemness (e.g., OCT4 and Nanog),
  and immune checkpoints (e.g., PD-L1) are upregulated.
papertitle: 'Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the
  current chemotherapy.'
reftext: Parham Jabbarzadeh Kaboli, et al. Am J Cancer Res. 2021;11(10):5155-5183.
year: '2021'
doi: ''
journal_title: American Journal of Cancer Research
journal_nlm_ta: Am J Cancer Res
publisher_name: e-Century Publishing Corporation
keywords: PI3K/Akt/mTOR inhibitor | breast cancer | drug resistance | targeted therapy
  | stress conditions
automl_pathway: 0.9662624
figid_alias: PMC8569340__F1
figtype: Figure
redirect_from: /figures/PMC8569340__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8569340__ajcr0011-5155-f1.html
  '@type': Dataset
  description: Akt as the master regulator of chemoresistance in breast cancer cells.
    Akt and its metabolic roles in breast cancer. PI3K activates Akt through Akt recruitment
    at the plasma membrane. In the case of RAS overactivation, KRAS alternatively
    activates Akt signalling in an RTK-independent manner. KRAS-dependent activation
    of Akt upregulates HIF-1α and Nrf2 transcription factors by which numerous genes
    related to glucose metabolism (e.g., glucose transporter 1), MDRs (e.g., BCRP,
    MDR1, and P-gp), antioxidants (e.g., HO-1 and NAD(P)H dehydrogenase 1/2), cancer
    stemness (e.g., OCT4 and Nanog), and immune checkpoints (e.g., PD-L1) are upregulated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Keap1
  - cnc
  - Glut1
  - Mdr65
  - Ho
  - Tie
  - Ras85D
  - InR
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Akt
  - ca
  - gs
  - sg
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GABPA
  - NFE2L2
  - SLC2A1
  - ABCB1
  - TBC1D9
  - CD274
  - HMOX1
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - NANOG
  - KRAS
  - NRAS
  - PTPA
  - AKT1
  - AKT2
  - AKT3
  - CIP2A
  - CRYGD
  - GNAS
  - GNAL
---
